COPD Fitz Flashcards

1
Q
  1. When discussing immunizations with a 67-year-old
    woman with chronic obstructive pulmonary disease
    (COPD), you advise that she:

A. receive live attenuated influenza virus vaccine.
B. avoid immunization against influenza because of the risk associated with the vaccine.
C. receive inactivated influenza virus vaccine.
D. take an antiviral for the duration of the influenza
season.

A

C. receive inactivated influenza virus vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Seasonal influenza vaccination is generally
    recommended for all persons over the age
    of 6 months.

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. A 66-year-old woman is an acceptable
    candidate for the high-dose inactivated
    influenza vaccine shot.

True or False

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Cigarette smokers should not receive the
    pneumococcal vaccine until 65 years of age.

True or False

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. A 52-year-old immunocompetent patient with
    COPD who receives the pneumococcal vaccine
    should get revaccinated in 5 years.

True or False

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. When used in treating COPD, ipratropium bromide
    (Atrovent®) is prescribed to achieve which of the
    following therapeutic effects?
    A. increase mucociliary clearance
    B. reduce alveolar volume
    C. bronchodilation
    D. mucolytic action
A

C. bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. What is the desired therapeutic action of inhaled
    corticosteroids when used to treat COPD?
    A. reversal of fixed airway obstruction
    B. improvement of central respiratory drive
    C. reduction of airway inflammation
    D. mucolytic activity
A

C. reduction of airway inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Which is most consistent with the diagnosis of COPD?
    A. FEV1/forced vital capacity (FVC) ratio equal to or
    less than 0.70 after properly timed SABA use
    B. dyspnea on exhalation
    C. elevated diaphragms noted on x-ray
    D. polycythemia noted on complete blood cell count
A

A. FEV1/forced vital capacity (FVC) ratio equal to or

less than 0.70 after properly timed SABA use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. The most effective nonpharmacologic method to
    prevent exacerbations in patients with COPD is:
    A. weight loss for those with a body mass index (BMI)
    greater than 25 kg/m2.
    B. avoid exposure to children or day-care centers.
    C. brisk walking for at least 5 minutes 3–5 times a day
    as tolerated.
    D. avoid exposure to pulmonary irritants, such as
    cigarette smoke.
A

D. avoid exposure to pulmonary irritants, such as

cigarette smoke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. When managing patients with COPD who continue to smoke cigarettes, a discussion on the importance of
    smoking cessation should occur:
    A. at the initial diagnosis visit.
    B. with each COPD flare.
    C. once inhaled corticosteroid therapy is initiated.
    D. at every office visit.
A

D. at every office visit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
43. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD guidelines, which of the following medications is indicated for use in all COPD stages?
A. short-acting inhaled beta2-agonist
B. inhaled corticosteroid
C. phosphodiesterase 4 (PDE-4) inhibitor
D. mucolytic
A

A. short-acting inhaled beta2-agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. According to the GOLD COPD guidelines, the goal of inhaled corticosteroid use in severe COPD is to:
    A. minimize the risk of repeated exacerbations.
    B. improve cough function.
    C. reverse alveolar hypertrophy.
    D. help mobilize secretions.
A

A. minimize the risk of repeated exacerbations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
45. Which of the following systemic corticosteroid doses is most potent?
A. methylprednisolone 8 mg
B. triamcinolone 10 mg
C. prednisone 15 mg
D. hydrocortisone 18 mg
A

C. prednisone 15 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
46. Which of the following pathogens is often implicated in a COPD exacerbation caused by respiratory tract infection?
A. Legionella species
B. Streptococcus pyogenes
C. respiratory tract viruses
D. Staphylococcus aureus
A

C. respiratory tract viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Which is the most appropriate choice of therapy in
    the treatment of a mild acute COPD exacerbation in
    a 42-year-old man?
    A. a 5-day course of levofloxacin
    B. a 7-day course of amoxicillin
    C. a 10-day course of doxycycline
    D. antimicrobial therapy usually not indicated
A

D. antimicrobial therapy usually not indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Which is the most appropriate statement about therapy for a severe COPD exacerbation in a 52-year-old man?
    A. A 5-day course of azithromycin should be prescribed.
    B. A 10-day course of amoxicillin/clavulanate is
    advisable,
    C. A 7-day course of trimethoprim-sulfamethoxazole
    (TMP-SMX) is recommended.
    D. The role of antimicrobial therapy is debated, even
    for a severe exacerbation.
A

D. The role of antimicrobial therapy is debated, even

for a severe exacerbation.

17
Q
49. You see a 67-year-old man with very severe (GOLD 4) COPD who asks, “When should I use my home oxygen?” You respond:
A. “As needed when short of breath.”
B. “Primarily during sleep hours.”
C. “Preferably during waking hours.”
D. “For at least 15 hours a day.”
A

D. “For at least 15 hours a day.”

18
Q
  1. With a COPD exacerbation, a chest x-ray should be obtained:
    A. routinely in all patients.
    B. when attempting to rule out a concomitant
    pneumonia.
    C. if sputum volume is increased.
    D. when work of breathing is increased.
A

B. when attempting to rule out a concomitant

pneumonia.

19
Q
  1. Which of the following best describes the role of
    theophylline in COPD treatment?
    A. routinely indicated in moderate to very severe
    COPD
    B. use limited by narrow therapeutic profile and
    drug–drug interaction potential
    C. a potent bronchodilator
    D. available only in parenteral form
A

B. use limited by narrow therapeutic profile and

drug–drug interaction potential

20
Q
  1. All of the following are consistent with the GOLD COPD recommendation for pulmonary rehabilitation except:
    A. it is reserved for very severe COPD.
    B. its goals include improvement in overall well-being.
    C. it is an underused therapeutic option.
    D. its components are aimed at reducing the deconditioning common in COPD.
A

A. it is reserved for very severe COPD.